Using a Recently Approved Tumor Mutational Burden Biomarker to Stratify Patients for Immunotherapy May Introduce a Sex Bias.
Neelam SinhaSanju SinhaKuoyuan ChengSanna MadanAyelet ErezBríd M RyanAlejandro A SchäfferKenneth D AldapeEytan RuppinPublished in: JCO precision oncology (2022)